Research advances in the influence of intraoperative factors during transjugular intrahepatic portosystemic shunt on the development of hepatic encephalopathy

Qi QI; Xin YAO; Guodong YANG; Jianping QIN

doi:10.3969/j.issn.1001-5256.2023.08.030

Volume 39 Issue 8

Aug. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(8): 1966-1971

PDF( 1681 KB)

Research advances in the influence of intraoperative factors during transjugular intrahepatic portosystemic shunt on the development of hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2023.08.030

Qi QI¹,
Xin YAO²,
Guodong YANG³,
Jianping QIN^{2
,
,
,}

1.
Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan 637000, China
2.
Department of Gastroenterology, The General Hospital of Western Theater Command of Chinese People's Liberation Army, Chengdu 610083, China
3.
Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China

Research funding:

Primal Chengdu Military General Hospital Fund Project (2013YG-B009)

More Information

Corresponding author: QIN Jianping, jpqqing@163.com (ORCID: 0000-0001-7834-8830)
Received Date: 2022-11-04
Accepted Date: 2022-12-05
Published Date: 2023-08-20

Abstract

Abstract

Hepatic encephalopathy (HE) is one of the common complications after transjugular intrahepatic portosystemic shunt (TIPS), with complex influencing factors and an unknown pathogenesis, and how to reduce HE after TIPS has always been a clinical concern. There are reports on the influence of TIPS on postoperative HE both in China and globally, and a consensus has been reached on some of the research results, while there are still controversies over other results. This article reviews the influencing factors for postoperative HE, such as puncture of the left or right portal vein shunt during TIPS, balloon dilatation channels with different inner diameters, and the degree of reduction in hepatic venous pressure gradient, so as to provide a reference for optimizing the operation of TIPS and reducing the onset of postoperative HE.
- Portasystemic Shunt, Transjugular Intrahepatic,
- Hepatic Encephalopathy,
- Liver Cirrhosis,
- Portal Hypertension

FullText(HTML)

References(35)

References

[1]	TRIPATHI D, STANLEY AJ, HAYES PC, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension[J]. Gut, 2020, 69(7): 1173-1192. DOI: 10.1136/gutjnl-2019-320221.
[2]	Chinese Society of Emergency Medicine, Interventional Physician Branch of Chinese Medical Doctor Association, Interventional Group of Radiology Society of Chinese Medical Association, et al. Expert consensus on emergency rescue for portal hypertension bleeding (2022)[J]. Chin J Intern Med, 2022, 61(5): 496-506. DOI: 10.3760/cma.j.cn112138-20210922-00653. 中华医学会急诊分会, 中国医师协会介入医师分会, 中华医学会放射学分会介入学组, 等. 门静脉高压出血急救流程专家共识(2022)[J]. 中华内科杂志, 2022, 61(5): 496-506. DOI: 10.3760/cma.j.cn112138-20210922-00653.
[3]	Chinese Medical Doctor Association Branch of Interventional Physicians. CCI clinical practice guidelines: Management of TIPS for portal hypertension (2019 edition)[J]. J Clin Hepatol, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010. 中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
[4]	RIGGIO O, RIDOLA L, ANGELONI S, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial[J]. J Hepatol, 2010, 53(2): 267-272. DOI: 10.1016/j.jhep.2010.02.033.
[5]	PRAKTIKNJO M, ABU-OMAR J, CHANG J, et al. Controlled underdilation using novel VIATORR^® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation[J]. JHEP Rep, 2021, 3(3): 100264. DOI: 10.1016/j.jhepr.2021.100264.
[6]	ZHOU S, YUAN M. The effect of TIPS combined with embolization of large spontaneous portosystemic shunt on postoperative hepatic encephalopathy[J]. Chin Hepatol, 2022, 27(10): 1067-1068. DOI: 10.3969/j.issn.1008-1704.2022.10.005. 周粟, 袁敏. TIPS联合栓塞粗大自发性门体分流道对术后肝性脑病的影响[J]. 肝脏, 2022, 27(10): 1067-1068. DOI: 10.3969/j.issn.1008-1704.2022.10.005.
[7]	LUO X, WANG X, ZHU Y, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene-covered stent-grafts: 8-mm versus 10-mm[J]. Cardiovasc Intervent Radiol, 2019, 42(5): 737-743. DOI: 10.1007/s00270-019-02162-4.
[8]	Chinese Society of Gastroenterology and Chinese Society of Hepatology, Chinese Medical Association. Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013)[J]. Chin J Dig, 2013, 33(9): 581-592. DOI: 10.3760/cma.j.issn.0254-1432.2013.09.002 中华医学会消化病学分会, 中华医学会肝病学分会. 中国肝性脑病诊治共识意见(2013年, 重庆)[J]. 中华消化杂志, 2013, 33(9): 581-592. DOI: 10.3760/cma.j.issn.0254-1432.2013.09.002.
[9]	FERENCI P, LOCKWOOD A, MULLEN K, et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998[J]. Hepatology, 2002, 35(3): 716-721. DOI: 10.1053/jhep.2002.31250.
[10]	BLEI AT, CÓRDOBA J, Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy[J]. Am J Gastroenterol, 2001, 96(7): 1968-1976. DOI: 10.1111/j.1572-0241.2001.03964.x.
[11]	BAJAJ JS, CORDOBA J, MULLEN KD, et al. Review article: the design of clinical trials in hepatic encephalopathy—an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement[J]. Aliment Pharmacol Ther, 2011, 33(7): 739-747. DOI: 10.1111/j.1365-2036.2011.04590.x.
[12]	CASADABAN LC, PARVINIAN A, MINOCHA J, et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes[J]. Dig Dis Sci, 2015, 60(4): 1059-1066. DOI: 10.1007/s10620-014-3391-0.
[13]	LUO SH, CHU JG, HUANG H, et al. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy[J]. World J Gastroenterol, 2019, 25(9): 1088-1099. DOI: 10.3748/wjg.v25.i9.1088.
[14]	MARUYAMA H, OKUGAWA H, ISHIBASHI H, et al. Carbon dioxide-based portography: an alternative to conventional imaging with the use of iodinated contrast medium[J]. J Gastroenterol Hepatol, 2010, 25(6): 1111-1116. DOI: 10.1111/j.1440-1746.2010.06248.x.
[15]	YAO X, HE S, WEI M, et al. Influence of different portal vein branches on hepatic encephalopathy during intrahepatic portal shunt via jugular vein[J]. World J Gastroenterol, 2022, 28(31): 4467-4470. DOI: 10.3748/wjg.v28.i31.4467.
[16]	LJUBICIĆN, DUVNJAK M, ROTKVIĆI, et al. Influence of the degree of liver failure on portal blood flow in patients with liver cirrhosis[J]. Scand J Gastroenterol, 1990, 25(4): 395-400. DOI: 10.3109/00365529009095505.
[17]	YAO X, ZHOU H, TANG SH, et al. Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2020, 36(9): 1970-1974. DOI: 10.3969/j.issn.1001-5256.2020.09.012. 姚欣, 周昊, 汤善宏, 等. 肝硬化门静脉高压患者行经颈静脉肝内门体分流术术中置入Viatorr支架分流门静脉左、右支血流对疗效的影响[J]. 临床肝胆病杂志, 2020, 36(9): 1970-1974. DOI: 10.3969/j.issn.1001-5256.2020.09.012.
[18]	DENG LYY, CHEN Y, YE P, et al. Preliminary analysis of liver - related blood components in portal vein system via TIPS approach[J]. J Intervent Radiol, 2020, 29(6): 608-611. DOI: 10.3969/j.issn.1008-794X.2020.06.018. 邓黎严琰, 陈勇, 叶鹏, 等. 经颈静脉肝内门体分流术初步分析门静脉系统肝脏相关血液成分[J]. 介入放射学杂志, 2020, 29(6): 608-611. DOI: 10.3969/j.issn.1008-794X.2020.06.018.
[19]	TENG D, ZUO H, LIU L, et al. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment[J]. Virol J, 2018, 15(1): 151. DOI: 10.1186/s12985-018-1067-7.
[20]	WANG Q, LV Y, BAI M, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding[J]. J Hepatol, 2017, 67(3): 508-516. DOI: 10.1016/j.jhep.2017.05.006.
[21]	ROWLEY MW, CHOI M, CHEN S, et al. Refractory hepatic encephalopathy after elective transjugular intrahepatic portosystemic shunt: risk factors and outcomes with revision[J]. Cardiovasc Intervent Radiol, 2018, 41(11): 1765-1772. DOI: 10.1007/s00270-018-1992-2.
[22]	QIN JP, JIANG MD, TANG W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center[J]. World J Gastroenterol, 2013, 19(44): 8085-8092. DOI: 10.3748/wjg.v19.i44.8085.
[23]	YAO X, ZHOU H, HUANG S, et al. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis[J]. World J Clin Cases, 2021, 9(7): 1532-1542. DOI: 10.12998/wjcc.v9.i7.1532.
[24]	CUI J, SMOLINSKI SE, LIU F, et al. Incrementally expandable transjugular intrahepatic portosystemic shunts: single-center experience[J]. AJR Am J Roentgenol, 2018, 210(2): 438-446. DOI: 10.2214/AJR.17.18222.
[25]	QIN JP, TANG SH, JIANG MD, et al. Contrast enhanced computed tomography and reconstruction of hepatic vascular system for transjugular intrahepatic portal systemic shunt puncture path planning[J]. World J Gastroenterol, 2015, 21(32): 9623-9629. DOI: 10.3748/wjg.v21.i32.9623.
[26]	SCHEPIS F, VIZZUTTI F, GARCIA-TSAO G, et al. Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2018, 16(7): 1153-1162. e7. DOI: 10.1016/j.cgh.2018.01.029.
[27]	YAO J, ZUO L, AN G, et al. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension[J]. J Gastrointestin Liver Dis, 2015, 24(3): 301-307. DOI: 10.15403/jgld.2014.1121.243.yao.
[28]	WAN YM, LI YH, XU ZY, et al. Transjugular intrahepatic portosystemic shunt: the impact of portal venous pressure declines on shunt patency and clinical efficacy[J]. Acad Radiol, 2019, 26(2): 188-195. DOI: 10.1016/j.acra.2018.05.015.
[29]	ELSAID MI, RUSTGI VK. Epidemiology of hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24(2): 157-174. DOI: 10.1016/j.cld.2020.01.001.
[30]	European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
[31]	de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ - Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
[32]	BOSCH J. Small diameter shunts should lead to safe expansion of the use of TIPS[J]. J Hepatol, 2021, 74(1): 230-234. DOI: 10.1016/j.jhep.2020.09.018.
[33]	BOYER TD, HASKAL ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009[J]. Hepatology, 2010, 51(1): 306. DOI: 10.1002/hep.23383.
[34]	BOIKE JR, THORNBURG BG, ASRANI SK, et al. North american practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662. e36. DOI: 10.1016/j.cgh.2021.07.018.
[35]	YAO X, HUANG S, ZHOU H, et al. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt[J]. World J Gastroenterol, 2021, 27(30): 5088-5099. DOI: 10.3748/wjg.v27.i30.5088.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (277) PDF downloads(43)

Research advances in the influence of intraoperative factors during transjugular intrahepatic portosystemic shunt on the development of hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2023.08.030

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research advances in the influence of intraoperative factors during transjugular intrahepatic portosystemic shunt on the development of hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2023.08.030

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content